Zhou et al. demonstrated that Twist1 markedly decreases osteosarcoma cell survival following cisplatin treatment partially by down-regulating the endothelin-1 (ET1)/endothelin A receptor (ETAR) signaling via inhibition of the PI3K/AKT pathway [121]. This evidence concerns the gene EDN1 and osteosarcoma.